Lame Dorela, Pianelli Michelangelo, Morsia Erika, Olivieri Attilio, Poloni Antonella
Universita Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
J Hematol. 2024 Aug;13(4):174-177. doi: 10.14740/jh1260. Epub 2024 Aug 15.
Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated condition causing organ swelling and fibrosis. Rarely, it coexists with primary immune thrombocytopenia (ITP), characterized by low platelet count (< 100 × 10/L) without an underlying cause. We present a case of a 56-year-old woman diagnosed with ITP in 2005, successfully treated with dexamethasone and intravenous immunoglobulins (IVIG). In 2011, she was diagnosed with IgG4-RD, type I autoimmune pancreatitis, initially treated with steroids then azathioprine with no response. ITP relapses were managed with prednisone/IVIG, rituximab, and thrombopoietin-receptor agonist therapy. Fostamatinib provided temporary relief, but platelet count dropped again in 2023. Combination therapy with small doses of prednisone and mycophenolate showed a partial response, maintaining platelet count over 50 × 10/L. Further investigation is warranted to explore any correlation between these two conditions, especially considering the patient's prolonged response to immunosuppressors.
免疫球蛋白G4相关性疾病(IgG4-RD)是一种免疫介导的疾病,可导致器官肿胀和纤维化。它很少与原发性免疫性血小板减少症(ITP)共存,ITP的特征是血小板计数低(<100×10⁹/L)且无潜在病因。我们报告一例56岁女性病例,该患者于2005年被诊断为ITP,接受地塞米松和静脉注射免疫球蛋白(IVIG)治疗成功。2011年,她被诊断为IgG4-RD,I型自身免疫性胰腺炎,最初用类固醇治疗,然后用硫唑嘌呤治疗,但无反应。ITP复发采用泼尼松/IVIG、利妥昔单抗和血小板生成素受体激动剂治疗。福斯他替尼提供了暂时缓解,但2023年血小板计数再次下降。小剂量泼尼松和霉酚酸酯联合治疗显示出部分反应,使血小板计数维持在50×10⁹/L以上。鉴于患者对免疫抑制剂的长期反应,有必要进一步研究这两种疾病之间的相关性。